↓ Skip to main content

Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy

Overview of attention for article published in Breast Cancer Research, January 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
57 X users
wikipedia
4 Wikipedia pages
reddit
2 Redditors

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy
Published in
Breast Cancer Research, January 2021
DOI 10.1186/s13058-021-01391-1
Pubmed ID
Authors

Xuanmao Jiao, Min Wang, Zhao Zhang, Zhiping Li, Dong Ni, Anthony W. Ashton, Hsin-Yao Tang, David W. Speicher, Richard G. Pestell

X Demographics

X Demographics

The data shown below were collected from the profiles of 57 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 14%
Researcher 5 12%
Student > Bachelor 3 7%
Professor 2 5%
Student > Ph. D. Student 2 5%
Other 5 12%
Unknown 19 45%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 14%
Medicine and Dentistry 6 14%
Agricultural and Biological Sciences 3 7%
Social Sciences 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Other 2 5%
Unknown 20 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 52. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2023.
All research outputs
#814,701
of 25,525,181 outputs
Outputs from Breast Cancer Research
#63
of 2,060 outputs
Outputs of similar age
#23,301
of 526,864 outputs
Outputs of similar age from Breast Cancer Research
#1
of 24 outputs
Altmetric has tracked 25,525,181 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,060 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 526,864 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.